Dr. Iftekhar A. Khan, MD
- Medicare services, 2024
- 595
- Medicare patients, 2024
- 281
- Part D claims, 2024
- 577
- Publications
- 7
- Clinical trials
- 10
- Practice address
- 640 S State Street, Dover, DE 19901
- Practice phone
- Call (302) 744-7001
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Khan's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Iftekhar A. Khan is a medical oncologist in Dover, Delaware
Dr. Khan practices at Bayhealth Hospital, Kent Campus in Dover, Delaware, part of Bayhealth Medical Center.
Dr. Khan's NPI, 1770566085, was assigned on November 22, 2005. Dr. Khan holds Delaware license C1-0006499.
- NPI
- 1770566085NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4789756966
- NPI enumeration date
- November 22, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (302) 744-7001
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 65
- Medical school graduation
- 1987
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Iftekhar A. Khan practices at Bayhealth Hospital, Kent Campus in Dover, Delaware
Dr. Khan's primary practice is Bayhealth Hospital, Kent Campus, at 640 S State Street, Dover, DE 19901 in Kent County. The practice phone is (302) 744-7001.
- Bayhealth Hospital, Kent Campus640 S State Street, Dover, DE 19901 · Kent CountyPhone(302) 744-7001
Source: Dmand AI Affiliation Data
Dr. Iftekhar A. Khan is affiliated with 2 sites of care and 1 medical group
Dr. Khan's primary practice is Bayhealth Hospital, Kent Campus in Dover, Delaware, part of Bayhealth Medical Center. Dr. Khan is also affiliated with Bayhealth Hospital, Sussex Campus. The medical group on file is Bayhealth.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Iftekhar A. Khan's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khan practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Bayhealth Hospital, Kent Campus | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Bayhealth Medical Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Iftekhar A. Khan is one of 11 medical oncologists in Delaware
Medical oncology is Dr. Khan's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Khan is licensed in Delaware.
Specialties and state licenses
- Medical oncology, DelawarePrimary
Medical oncologists near Dr. Khan
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Iftekhar A. Khan billed Medicare for 595 services in 2024
CMS data shows 595 Medicare services from Dr. Khan across 5 procedure codes in 2024, for 281 Medicare patients. Medicare paid $32,676 for them.
Dr. Khan's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 9012024: 59534%
Where Dr. Khan's Medicare services took place, 2024
- In an office8114%
- In a facility51486%
Dr. Khan's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Khan?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Khan and other medical oncologists in Delaware.
Source: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data
Dr. Iftekhar A. Khan treated 281 Medicare patients in 2024, average age 75
CMS counts 281 Medicare patients who saw Dr. Khan in 2024. The largest group is 75 to 84, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Khan's median patient age at 75, with 59% women.
Dr. Khan's Medicare patients by age, 2024
Dr. Khan's Medicare patients by sex, 2024
- Women16358%
- Men11842%
Chronic conditions among Dr. Khan's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis46%
- Diabetes42%
- Cancer41%
- Chronic kidney disease38%
- Ischemic heart disease33%
- COPD26%
Share of Medicare patients with each condition. A patient can have several.
Dr. Khan's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 75
Patient panel by sex, all payers
- Women59%
- Men40%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Iftekhar A. Khan wrote 577 Medicare Part D claims in 2024
In 2024, Dr. Khan wrote 577 Medicare Part D claims for 120 patients. 63% of them were for generic drugs. CMS names the drug for 445 of them, across 16 drugs with 11 or more claims each, at $1,049,906 in total drug cost. In 2023, CMS named 592 claims across 16 drugs.
Dr. Khan's Part D claims by kind of drug, 2024
- Generic362 claims63%
- Brand-name215 claims37%
Dr. Khan's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Khan's Part D claims, 2024
- Opioids11%64 of 577 claims
- Antibiotics3%19 of 577 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 5922024: 44525%
Drugs named by CMS: 16 in 2024, 16 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Iftekhar A. Khan offers telehealth to Medicare patients
Dr. Khan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khan as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Iftekhar A. Khan has 7 publications on record
Dmand AI links 7 papers to Dr. Khan, published from 2020 to 2024. Dr. Khan has published most often in Indian J Dermatol Venereol Leprol. Dr. Khan's most frequent co-authors are Abeer A. Alfaraj, MD, David Chan, MD and Marisa E. Hill, MD.
Dr. Khan's papers by year, 2020 to 2024
Dr. Khan's most frequent co-authors
Recent publications by Dr. Khan
Cancer Epidemiol Biomarkers Prev
See who Dr. Khan researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Khan works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Iftekhar A. Khan has worked on 10 clinical trials
Dmand AI links Dr. Khan to 10 clinical trials, 5 of them phase 3 studies. 8 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Breast Neoplasms. National Cancer Institute (NCI) sponsors the most, 6.
Clinical trials with Dr. Khan by phase
- NonePhase 1: no trials
- 4Phase 2: 4 trials
- 5Phase 3: 5 trials
- NonePhase 4: no trials
Conditions in Dr. Khan's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
- Breast Neoplasms
- Breast Diseases
- Adenocarcinoma of Lung
Investigators on the most trials with Dr. Khan
- Serge Dauphin, MD4 shared trials
- Vinay Kumar Gudena, MD4 shared trials
- Susanna Hong, MD4 shared trials
Recent clinical trials with Dr. Khan
FDG PET to Assess Therapeutic Response in Patients With Bone-Dominant Metastatic Breast Cancer, FEATURE (opens in a new tab)
Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC (opens in a new tab)
Cabazitaxel With Abiraterone Versus Abiraterone Alone Randomized Trial for Extensive Disease Following Docetaxel: The CHAARTED2 Trial (opens in a new tab)
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Iftekhar A. Khan received $190 in industry payments from 2016 to 2023
CMS Open Payments shows 7 general payments to Dr. Khan from 4 drug and device companies from 2016 to 2023. Education make up the largest share, 76% of the total. Millennium Pharmaceuticals, Inc. paid the most, $89.
General payments to Dr. Khan by program year, 2016 to 2023
General payments to Dr. Khan by kind, 2016 to 2023
- Education$14576%
- Food and beverage$4524%
Companies that paid Dr. Khan the most, 2016 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Iftekhar A. Khan's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Iftekhar A. Khan
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Iftekhar A. Khan's NPI number?
Dr. Iftekhar A. Khan's NPI number is 1770566085. It was assigned on November 22, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Iftekhar A. Khan?
Dr. Iftekhar A. Khan is a medical oncologist in Dover, Delaware. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Iftekhar A. Khan practice?
Dr. Khan practices at 640 S State Street, Dover, DE 19901. Dr. Khan's primary practice is Bayhealth Hospital, Kent Campus in Dover, Delaware, part of Bayhealth Medical Center.
What is Dr. Iftekhar A. Khan's office phone number?
The practice phone on file for Dr. Khan is (302) 744-7001.
What is Dr. Iftekhar A. Khan's medical license number?
Dr. Khan holds Delaware license C1-0006499.
Which hospitals is Dr. Iftekhar A. Khan affiliated with?
Dr. Khan practices at Bayhealth Hospital, Kent Campus in Dover, Delaware. Dr. Khan is also affiliated with Bayhealth Hospital, Sussex Campus.
What medical group is Dr. Iftekhar A. Khan part of?
Dr. Khan is linked to Bayhealth.
Does Dr. Iftekhar A. Khan accept Medicare?
Yes. CMS data shows Dr. Khan billed Medicare for 595 services in 2024, and Dr. Khan accepts Medicare assignment.
Does Dr. Iftekhar A. Khan offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Khan as offering telehealth services.
How many Medicare patients does Dr. Iftekhar A. Khan see?
CMS counts 281 Medicare patients who saw Dr. Khan in 2024, with an average age of 75.
Show 6 more questionsShow fewer questions
What services does Dr. Iftekhar A. Khan bill to Medicare?
In 2024, Dr. Khan's most billed Medicare services were office visit, established patient (99213), office visit, established patient (99214) and care management and other visits (99442).
What drugs does Dr. Iftekhar A. Khan prescribe most?
In 2024 Medicare Part D data, Dr. Khan's most prescribed drugs by claims were Eliquis, Anastrozole and Xarelto.
Has Dr. Iftekhar A. Khan received payments from drug or device companies?
CMS Open Payments shows $190 in general payments to Dr. Khan from 4 companies from 2016 to 2023. The largest total came from Millennium Pharmaceuticals, Inc.
How long has Dr. Iftekhar A. Khan been practicing?
Dr. Khan graduated from medical school in 1987, 39 years ago.
Does Dr. Iftekhar A. Khan do research?
Dmand AI links 7 publications to Dr. Khan, published from 2020 to 2024. Dr. Khan has worked on 10 clinical trials.
Who does Dr. Iftekhar A. Khan publish with?
Dr. Khan's most frequent co-authors are Abeer A. Alfaraj, MD (1 shared paper), David Chan, MD (1 shared paper) and Marisa E. Hill, MD (1 shared paper).
Selling to medical oncology practices?
See medical oncologists in Delaware by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card